Sonoma Pharmaceuticals
SNOA
#10631
Rank
NZ$6.61 M
Marketcap
NZ$1.90
Share price
2.70%
Change (1 day)
-66.27%
Change (1 year)

Earnings for Sonoma Pharmaceuticals (SNOA)

Earnings in 2025 (TTM): -NZ$5.37 Million

According to Sonoma Pharmaceuticals's latest financial reports the company's current earnings are NZ$16.93 Million. In 2024 the company made an earning of -NZ$7.46 Million a decrease over its 2023 earnings that were of -NZ$7.42 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Sonoma Pharmaceuticals from 2005 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -NZ$5.37 Million-28.01%
2024 -NZ$7.46 Million0.54%
2023 -NZ$7.42 Million-31.5%
2022 -NZ$10.82 Million16.86%
2021 -NZ$9.26 Million194.32%
2020 -NZ$3.15 Million-58.76%
2019 -NZ$7.63 Million-65.66%
2018 -NZ$22.21 Million4.84%
2017 -NZ$21.19 Million-2.17%
2016 -NZ$21.66 Million32.12%
2015 -NZ$16.4 Million-307.74%
2014 NZ$7.88 M-197.5%
2013 -NZ$8.1 Million
2010 -NZ$12.65 Million-14.02%
2009 -NZ$14.71 Million-57.28%
2008 -NZ$34.42 Million-8.03%
2007 -NZ$37.43 Million3.85%
2006 -NZ$36.04 Million39.31%
2005 -NZ$25.87 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
OPKO Health
OPK
-NZ$0.27 Billion 5,013.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Onconova Therapeutics
ONTX
-NZ$30.31 Million 482.11%๐Ÿ‡บ๐Ÿ‡ธ USA